Garrison LP Jr - Search Results

1

An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases.

Yang M, Mittal M, Fendrick AM, Brixner D, Sherman BW, Liu Y, Patel P, Clewell J, Liu Q, Garrison LP Jr. Yang M, et al. Among authors: garrison lp jr. Adv Ther. 2024 Dec 20. doi: 10.1007/s12325-024-03076-5. Online ahead of print. Adv Ther. 2024. PMID: 39704878

2

Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer's Disease in the United States.

Boustani M, Doty EG, Garrison LP Jr, Smolen LJ, Klein TM, Murphy DR, Spargo AW, Belger M, Johnston JA. Boustani M, et al. Among authors: garrison lp jr. Neurol Ther. 2024 Dec;13(6):1641-1659. doi: 10.1007/s40120-024-00649-y. Epub 2024 Sep 18. Neurol Ther. 2024. PMID: 39292433 Free PMC article.

3

Why is the market design for innovative pharmaceuticals not well understood?

Olivença F, Diaz J, Ramagopalan SV, Garrison LP Jr. Olivença F, et al. Among authors: garrison lp jr. J Comp Eff Res. 2024 Oct;13(10):e240105. doi: 10.57264/cer-2024-0105. Epub 2024 Sep 10. J Comp Eff Res. 2024. PMID: 39254992 Free PMC article. No abstract available.

4

Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US Oncologists.

Li M, Elsisi Z, Wong W, Kowal S, Veenstra DL, Garrison LP Jr. Li M, et al. Among authors: garrison lp jr. Value Health. 2024 Dec;27(12):1671-1678. doi: 10.1016/j.jval.2024.07.021. Epub 2024 Aug 9. Value Health. 2024. PMID: 39127254

5

Val (EU) xit: do we need an international ISPOR value flower?

Ramagopalan SV, Gomes M, Durand-Zaleski I, Malcolm B, Diaz J, Mitchell G, Pearson-Stuttard J, Garrison LP Jr. Ramagopalan SV, et al. Among authors: garrison lp jr. J Comp Eff Res. 2024 Sep;13(9):e240083. doi: 10.57264/cer-2024-0083. Epub 2024 Jul 19. J Comp Eff Res. 2024. PMID: 39028108 Free PMC article. No abstract available.

6

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019.

Garrison LP Jr, Jiao B, Elsisi Z, Yehoshua A, Koruth R, Kreter B, Grueger J. Garrison LP Jr, et al. Value Health. 2024 Aug;27(8):1021-1029. doi: 10.1016/j.jval.2024.04.011. Epub 2024 Apr 23. Value Health. 2024. PMID: 38663800 Free article.

7

New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.

Buck PO, Gomes DA, Beck E, Kirson N, Mattera M, Carroll S, Ultsch B, Jayasundara K, Uhart M, Garrison LP Jr. Buck PO, et al. Among authors: garrison lp jr. Vaccines (Basel). 2024 Feb 24;12(3):234. doi: 10.3390/vaccines12030234. Vaccines (Basel). 2024. PMID: 38543868 Free PMC article.

8

Is the price right? Paying for value today to get more value tomorrow.

Ramagopalan SV, Diaz J, Mitchell G, Garrison LP Jr, Kolchinsky P. Ramagopalan SV, et al. Among authors: garrison lp jr. BMC Med. 2024 Jan 30;22(1):45. doi: 10.1186/s12916-024-03262-w. BMC Med. 2024. PMID: 38287326 Free PMC article.

9

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework.

Jiao B, Carlson JJ, Garrison LP Jr, Basu A. Jiao B, et al. Among authors: garrison lp jr. Value Health. 2024 Apr;27(4):433-440. doi: 10.1016/j.jval.2023.12.013. Epub 2024 Jan 6. Value Health. 2024. PMID: 38191022

10

Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?

Garrison LP Jr. Garrison LP Jr. Value Health. 2024 Jan;27(1):3-6. doi: 10.1016/j.jval.2023.10.010. Epub 2023 Nov 2. Value Health. 2024. PMID: 37918665 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters